CGRP monoclonal antibodies : summary and effectiveness - Migraine
4.8 (519) · € 20.50 · En Stock
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis, The Journal of Headache and Pain
New horizons in migraine therapy: CGRP monoclonal antibodies
Full article: Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention - ScienceDirect
Identifying New Antimigraine Targets: Lessons from Molecular Biology: Trends in Pharmacological Sciences
CGRP Monoclonal Antibodies: access, and coverage - Migraine Canada™
Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials
An Overview of New Biologics for Migraine Prophylaxis
Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials - Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul, 2023
Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials - Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul, 2023
Therapeutic novelties in migraine: new drugs, new hope?, The Journal of Headache and Pain
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study, The Journal of Headache and Pain
Pharmaceuticals, Free Full-Text
